BACKGROUND: Acute kidney injury (AKI) is common in critically ill children with significant mortality and morbidity. Serum creatinine is an insensitive and late biomarker compared to newly proposed AKI biomarkers. METHODS: Prospective study in pediatric intensive care unit (PICU) over three months to compare between serum cystatin-C (s-Cys-C) and urinary neutrophil gelatinase-associated lipocalin (uNGAL) as AKI biomarkers at multiple time points with pediatric risk, injury, failure, loss, end-stage renal disease (pRIFLE) classification in diagnosing AKI. RESULTS: Forty children were recruited. Of these 40 children, 22 developed AKI according to pRIFLE criteria. There was no significant difference between AKI and non-AKI in age (P = 0.29). Post cardiac surgery, renal insult was the main cause of AKI (27.3%). There was a twofold increased risk of incident AKI in those patients with high baseline uNGAL at PICU admission and almost a fourfold increased risk in patients with high baseline s-Cys-C at PICU admission. uNGAL levels were highly predictive of AKI during the follow-up period [area under the curve (AUC) = 0.76, 95% confidence interval (CI) 0.61-0.92]. The cutoff point with the highest correctly classified proportion was 223 ng/mL (≥ 12 centiles) which correctly predict 80.0% patients with AKI, with a corresponding sensitivity of 72.7% and a specificity of 89.9%. AUC for s-Cys-C was 0.86 (95% CI 0.75-0.97), and the highest correctly classified proportion was 1009 µg/L (≥ 13 centiles); 75% of patients with AKI, with a corresponding sensitivity of 63.6% and a specificity of 88.9%. CONCLUSION: uNGAL and s-Cys-C predicts AKI early in critically ill children.
BACKGROUND:Acute kidney injury (AKI) is common in critically ill children with significant mortality and morbidity. Serum creatinine is an insensitive and late biomarker compared to newly proposed AKI biomarkers. METHODS: Prospective study in pediatric intensive care unit (PICU) over three months to compare between serum cystatin-C (s-Cys-C) and urinary neutrophil gelatinase-associated lipocalin (uNGAL) as AKI biomarkers at multiple time points with pediatric risk, injury, failure, loss, end-stage renal disease (pRIFLE) classification in diagnosing AKI. RESULTS: Forty children were recruited. Of these 40 children, 22 developed AKI according to pRIFLE criteria. There was no significant difference between AKI and non-AKI in age (P = 0.29). Post cardiac surgery, renal insult was the main cause of AKI (27.3%). There was a twofold increased risk of incident AKI in those patients with high baseline uNGAL at PICU admission and almost a fourfold increased risk in patients with high baseline s-Cys-C at PICU admission. uNGAL levels were highly predictive of AKI during the follow-up period [area under the curve (AUC) = 0.76, 95% confidence interval (CI) 0.61-0.92]. The cutoff point with the highest correctly classified proportion was 223 ng/mL (≥ 12 centiles) which correctly predict 80.0% patients with AKI, with a corresponding sensitivity of 72.7% and a specificity of 89.9%. AUC for s-Cys-C was 0.86 (95% CI 0.75-0.97), and the highest correctly classified proportion was 1009 µg/L (≥ 13 centiles); 75% of patients with AKI, with a corresponding sensitivity of 63.6% and a specificity of 88.9%. CONCLUSION: uNGAL and s-Cys-C predicts AKI early in critically ill children.
Entities:
Keywords:
Acute kidney injury; Neutrophil gelatinase-associated lipocalin; Serum cystatin C
Authors: Mohammed Shalaby; Norah Khathlan; Osama Safder; Fatina Fadel; Youssef M K Farag; Ajay K Singh; Jameela A Kari Journal: Clin Nephrol Date: 2014-12 Impact factor: 0.975
Authors: Omar Alkandari; K Allen Eddington; Ayaz Hyder; France Gauvin; Thierry Ducruet; Ronald Gottesman; Véronique Phan; Michael Zappitelli Journal: Crit Care Date: 2011-06-10 Impact factor: 9.097
Authors: Alexandra J M Zwiers; Saskia N de Wildt; Joost van Rosmalen; Yolanda B de Rijke; Erik A B Buijs; Dick Tibboel; Karlien Cransberg Journal: Crit Care Date: 2015-04-21 Impact factor: 9.097
Authors: James McCaffrey; Beatrice Coupes; Chris Chaloner; Nicholas J A Webb; Rachael Barber; Rachel Lennon Journal: Pediatr Nephrol Date: 2015-04-15 Impact factor: 3.714
Authors: C A Palm; G Segev; L D Cowgill; B E LeRoy; K L Kowalkowski; K Kanakubo; J L Westropp Journal: J Vet Intern Med Date: 2016-01-04 Impact factor: 3.333
Authors: Osama Y Safdar; Mohammed Shalaby; Norah Khathlan; Bassem Elattal; Mohammed Bin Joubah; Esraa Bukahri; Mafaza Saber; Arwa Alahadal; Hala Aljariry; Safaa Gasim; Afnan Hadadi; Abdullah Alqahtani; Roaa Awleyakhan; Jameela A Kari Journal: BMC Nephrol Date: 2016-09-13 Impact factor: 2.388